JOURNAL OF CRANIOFACIAL SURGERY, vol.27, no.5, pp.1367-1370, 2016 (SCI-Expanded)
Objective: In previous studies, it has been shown that both simvastatin (chlolesterollowering drug) and platelet-rich plasma (PRP) were capable of promoting bone formation. The aim of this study was to compare the effects of PRP and simvastatin on healing of critical-size bone defects.